Prats E, Carril J, Herranz R, Meroño E, Banzo J, Gtemegmmt Y E
Servicio de Medicina Nuclear, Hospital Clínico Universitario,, Zaragoza, 50009, España.
Rev Esp Med Nucl. 1998;17(5):338-50.
The aim of this work has been to study, with a homogenous method, a wide sample of patients with breast cancer suspicion, in order to evaluate the real clinical usefulness of the scintimammography with MIBI-99mTc.
We have studied by way of prone scintimammography 388 patients (418 lesions) with breast cancer suspicion. In the mammography the size and degree of breast cancer suspicion was evaluated. Diagnosis was established by biopsy.
247 lesions were diagnosed as breast cancer and 171 as benign diseases. She results of the scintimammography were sensitivity 90%, specificity 70%, PPV 81% and NPV 83%. In palpable lesions sensitivity and specificity were 94% and 61%, and in non-palpable lesions 75% and 81% respectively. In 264 lesions mammographic breast cancer suspicion was establish. 13 of the 14 FN results were obtained in lesions with a high malignancy suspicion. In lesions with a low or indeterminate suspicion, sensitivity and NPV of the scintimammography were 97% and 98%.
Scintimammography has a high sensitivity but a relatively low specificity in the study of lesions with breast cancer suspicion. Scintimammography could be a good complement of the mammography in lesions with a low or indeterminate suspicion of malignancy.
本研究旨在采用统一方法,对大量疑似乳腺癌患者进行研究,以评估99mTc-MIBI乳腺闪烁显像的实际临床应用价值。
我们通过俯卧位乳腺闪烁显像对388例(418个病灶)疑似乳腺癌患者进行了研究。在乳腺钼靶检查中评估了乳腺癌的大小和疑似程度。通过活检确定诊断。
247个病灶被诊断为乳腺癌,171个为良性疾病。乳腺闪烁显像的结果为敏感性90%、特异性70%、阳性预测值81%和阴性预测值83%。在可触及病灶中,敏感性和特异性分别为94%和61%,在不可触及病灶中分别为75%和81%。在264个病灶中确定了乳腺钼靶检查对乳腺癌的疑似情况。14例假阴性结果中的13个出现在高度怀疑恶性的病灶中。在低度或不确定怀疑的病灶中,乳腺闪烁显像的敏感性和阴性预测值分别为97%和98%。
乳腺闪烁显像在疑似乳腺癌病灶的研究中具有较高的敏感性,但特异性相对较低。在低度或不确定怀疑恶性的病灶中,乳腺闪烁显像可作为乳腺钼靶检查的良好补充。